"Study Reveals Shocking Discrepancy in Cost of Ozempic Diabetes Drug Production"

A study by researchers at Yale University, King’s College Hospital, and Doctors Without Borders found that the popular diabetes and obesity drug Ozempic could be produced for less than $5 a month, while Novo Nordisk charges almost $1,000 in the US. The study raises questions about drug pricing and profit margins, with Senator Bernie Sanders calling for a lower list price. Novo Nordisk declined to provide production costs but emphasized its investments to ensure public access to its drugs. The study highlights the immense profit margin on drugs like Ozempic and underlines longstanding criticism of high prices for diabetes therapies, especially insulin.